|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 47/54 | |
| A61K 47/60 | |||
| A61K 38/12 | |||
| A61K 45/06 | |||
| C07K 14/47 |
| (11) | Patento numeris | 3247405 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16701560.1 |
| Europos patento paraiškos padavimo data | 2016-01-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-11-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-07-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2016/050206 |
| Data | 2016-01-15 |
| (87) | Numeris | WO 2016/116842 |
| Data | 2016-07-28 |
| (30) | Numeris | Data | Šalis |
| 201562107040 P | 2015-01-23 | US |
| (72) |
KANTER, Aaron, US
USERA, Aimee Richardson, US
ZECRI, Frederic, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | SYNTHETIC APELIN FATTY ACID CONJUGATES WITH IMPROVED HALF-LIFE |
| SYNTHETIC APELIN FATTY ACID CONJUGATES WITH IMPROVED HALF-LIFE |